Pharmacures Inc., is a contract development and manufacturing organization (CDMO) for Pharmaceutical, Nutraceutical Products worldwide.
Pharmacures Inc. niche in this growing CDMO market has been as a full- service provider focused on 505B2 drugs candidates. However, the business model shifted in the past couple of years to accommodate Nutraceutical products contract development and manufacturing activities.
The Contract Research and manufacturing business focused in Gum delivery technology, orally disintegrating tablets (ODT), Capsules, conventional tableting and taste masking. However, developments in other pharmaceutical delivery systems will be considered for Contract Research and internal research. Using our chewing gum-patented technology, we are always ready to develop and manufacture your products.
Pharmacures pioneered the development and manufacturing Pharmaceutical, Nutraceutical products.
Establish a defensible, approved and competitive technology position for oral delivery of targeted blockbuster pharmaceutical products whose patents will expire in 2022 or shortly thereafter.
As necessary, undertake contract research and/or establish an intellectual property licensing position with a contract pharmaceuticals manufacturer to provide additional cash for ongoing operations. Achieve a single blockbuster pharmaceutical product “win”.
Establish a commercial scale pharmaceutical product manufacturing capability.
Products are manufactured in cGMP facility
We offer competitive prices with friendly and reliable customer service
The Contract Research business unit performs specific customer requested research specializing in gum delivery technology, orally disintegrating tablets (ODT), and taste masking and more. However, developments in any pharmaceutical delivery system will be considered for Contract Research.
The Pharmaceutical Projects business unit will consider over the counter (OTC) Nutraceutical, prescription drugs products. In this arena Pharmacures is seeking to develop significant financial impact products through ANDA’s or 505B2 application.
We have specialized in the design, assessment, and implementation of Chewing Gum Drug Delivery, Oral Disintegrating Tablets (ODT), Taste Masking, and Conventional Tableting and Encapsulation Technologies.